MA49910B1 - Pyruvate kinase activators for use in the treatment of blood disorders - Google Patents

Pyruvate kinase activators for use in the treatment of blood disorders

Info

Publication number
MA49910B1
MA49910B1 MA49910A MA49910A MA49910B1 MA 49910 B1 MA49910 B1 MA 49910B1 MA 49910 A MA49910 A MA 49910A MA 49910 A MA49910 A MA 49910A MA 49910 B1 MA49910 B1 MA 49910B1
Authority
MA
Morocco
Prior art keywords
treatment
pyruvate kinase
blood disorders
kinase activators
activators
Prior art date
Application number
MA49910A
Other languages
French (fr)
Inventor
Giovanni Cianchetta
Zhihua Sui
Tao Liu
Anil Padyana
Zhenwei Cai
Dawei Cui
Jingjing Ji
Original Assignee
Agios Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agios Pharmaceuticals Inc filed Critical Agios Pharmaceuticals Inc
Priority claimed from PCT/US2018/000128 external-priority patent/WO2019035864A1/en
Publication of MA49910B1 publication Critical patent/MA49910B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés qui activent la pyruvate kinase, des compositions pharmaceutiques et des procédés d'utilisation de ceux-ci. Ces composés sont représentés par la formule (i) dans laquelle r1, r2, ra, rb, rj, rk, et q sont tels que définis dans la description.The invention relates to compounds which activate pyruvate kinase, pharmaceutical compositions and methods of use thereof. These compounds are represented by formula (i) in which r1, r2, ra, rb, rj, rk, and q are as defined in the description.

MA49910A 2018-05-18 2018-08-15 Pyruvate kinase activators for use in the treatment of blood disorders MA49910B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862673526P 2018-05-18 2018-05-18
PCT/US2018/000128 WO2019035864A1 (en) 2017-08-15 2018-08-15 Pyruvate kinase activators for use in treating blood disorders

Publications (1)

Publication Number Publication Date
MA49910B1 true MA49910B1 (en) 2021-11-30

Family

ID=78818912

Family Applications (1)

Application Number Title Priority Date Filing Date
MA49910A MA49910B1 (en) 2018-05-18 2018-08-15 Pyruvate kinase activators for use in the treatment of blood disorders

Country Status (1)

Country Link
MA (1) MA49910B1 (en)

Similar Documents

Publication Publication Date Title
MA42239B1 (en) New hydroxyester derivatives, their preparation process and pharmaceutical compositions containing them
MA40290A1 (en) Immune-regulating agents
MA34361B1 (en) TETRAHYDRO-PYRIDO-PYRIMIDINE DERIVATIVES
MA50240B1 (en) Cystic fibrosis transmembrane conductance regulatory protein modulators and methods of use
MA40111B1 (en) Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein
MA41562A1 (en) 4-hydroxy-3- (heteroaryl) pyridine-2-one agonists for use in the treatment of cardiovascular disorders
MA43979B1 (en) 1h-indazole-3-carboxamide derivatives and similar compounds as d-factor inhibitors for the treatment of diseases characterized by aberrant activity of the complementary system, such as p.E. Immunological disorders
MA43639B1 (en) New ammonium derivatives, process for their preparation and pharmaceutical compositions containing them
MA42410B1 (en) Oxysterols and their methods of use
MA39783A (en) USEFUL QUINOXALINE DERIVATIVES AS FGFR KINASE MODULATORS
MA31683B1 (en) Fxr modulation components and methods
MA54386B1 (en) TREX1 MODULATORS
MA53399B1 (en) Substituted pyrazoles as inhibitors of human plasma kallikrein
MA41389A1 (en) Use of tricyclic sulfones as modulators of rory
MA34474B1 (en) AGONISTS OF GPR40
MA46101A (en) POSITIVE ALLOSTERIC MODULATORS OF THE M1 MUSCARINIC RECEPTOR
MA35342B1 (en) Piperidinyl compounds useful as inhibitors of tankyrase
MA29377B1 (en) PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
MA34308B1 (en) SUBSTITUTED TRIAZOLOPYRIDINES
TN2016000188A1 (en) 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
MA30539B1 (en) PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES INDUCED BY THE GPR38 RECEPTOR.
MA49127B1 (en) N-substituted indole derivatives
MA46229B1 (en) Heteroaryl carboxamide compounds as inhibitors of ripk2
MA43913A (en) POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC M1 RECEPTOR
MA43052B1 (en) Human Plasma Kallikrein Inhibitors